abstract |
Antioxidant or combination of antioxidants which function particularly well in modulating the action of free radicals and in particular which function particularly well in regulating activation of a transcription factor, such as NF-kappa B and which can be non-toxically administered to a human or an animal are disclosed. In particular a method of treating diseases, including reduction of the incidence of lung cancers in tobacco smokers, using a tocotrienol and alpha-lipoic acid or tocotrienyl lipoate or derivatives thereof is disclosed. |